Public Profile

Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc., headquartered in the United States, is a pioneering company in the biopharmaceutical industry, specialising in the development of innovative therapies for cancer treatment. Founded in 2020, the company has quickly established itself as a leader in precision medicine, focusing on targeted therapies that enhance patient outcomes. With a commitment to advancing cancer care, Perspective Therapeutics offers unique products that leverage cutting-edge technology and research. Their core services include the development of novel drug candidates designed to address unmet medical needs in oncology. The company’s strategic approach and dedication to scientific excellence have positioned it as a notable player in the competitive landscape of cancer therapeutics, driving significant advancements in treatment methodologies.

DitchCarbon Score

How does Perspective Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Perspective Therapeutics, Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

84%

Perspective Therapeutics, Inc.'s reported carbon emissions

Perspective Therapeutics, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of data does not preclude the company from engaging in sustainability initiatives or aligning with industry standards for climate action. As the focus on environmental responsibility intensifies, it is essential for companies like Perspective Therapeutics to establish clear climate commitments and reduction strategies to contribute to global efforts in mitigating climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Perspective Therapeutics, Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Perspective Therapeutics, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Perspective Therapeutics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

AVEO Pharmaceuticals, Inc.

US
Health and social work services (85)
Updated 7 days ago
DitchCarbon Score

Cyclacel Pharmaceuticals, Inc.

US
Health and social work services (85)
Updated 7 days ago

Varian

US
Fabricated metal products, except machinery and equipment (28)
Updated 7 days ago

Elekta

SE
Health and social work services (85)
Updated 1 day ago

Traws Pharma, Inc.

US
Health and social work services (85)
Updated 7 days ago

Theragenics Corporation

US
Health and social work services (85)
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers